Trial Profile
A Randomized, Assessor-blind Trial Comparing MENOPUR (Menotropins for Injection) and Recombinant FSH (Follicle Stimulating Hormone) in a GnRH Antagonist Cycle With Single-Blastocyst Transfer in a High Responder Subject Population
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Feb 2022
Price :
$35
*
At a glance
- Drugs Menotropin (Primary) ; Follitropin alfa
- Indications Female infertility
- Focus Therapeutic Use
- Acronyms MEGASET HR
- Sponsors Ferring Pharmaceuticals
- 14 Oct 2021 According to a Ferring Pharmaceuticals media release, a sub analysis of data from the study will be presented at the American Society for Reproductive Medicine (ASRM) 2021 Scientific Congress & Expo.
- 21 Oct 2020 Results of post hoc analysis presented at the American Society for Reproductive Medicine Scientific Congress 2020
- 21 Oct 2020 Results of post-hoc analysis assessing possible interactions between treatment groups (HP-hMG or rFSH) and ovarian reserve presented at the American Society for Reproductive Medicine Scientific Congress 2020